SPIE Life Science Engineering GmbH acquires nimeg ag
nimeg ag, headquartered in Baden-Daettwil in the Canton of Aargau, specializes in engineering, planning and project management services in the GMP environment for EPCMV projects (Engineering, Procurement, Construction Management and Validation). The medium-sized company has extensive engineering expertise in the planning and management of complex GMP projects and serves a high-quality customer base in the life sciences industry, particularly in the pharmaceutical, chemical, biotechnology and medical technology sectors.
SPIE Life Science Engineering GmbH, headquartered in Nuremberg, is a German subsidiary of the listed SPIE Group, a leading European provider of multi-technical services. As a specialized engineering partner for the life sciences industry, SPIE Life Science Engineering plans and realizes sophisticated pharmaceutical and biotechnology projects as well as manufacturing areas in the GMP environment, offering comprehensive expertise along the entire project lifecycle – from consulting and planning through to realization, qualification and validation.
Through the acquisition, nimeg ag gains access to a strong industrial partner with an international platform and extensive expertise in life sciences engineering. At the same time, SPIE can further expand its market position in Switzerland and offer comprehensive EPCMV and EPC projects to customers from a single source.
The BDO M&A team acted as lead advisor to the owner of nimeg ag in connection with the acquisition by SPIE Life Science Engineering GmbH. BDO provided comprehensive support throughout the sale process and advised the seller in particular on the preparation and structuring of the process, the approach of potential buyers, the due diligence process and the negotiations through to the successful completion of the transaction.
If you have any questions or require further information, our contacts will be happy to assist you.
The BDO team
- Christian Ryf (Deal Advisory M&A)
- Janis Kessi (Deal Advisory M&A)
